Comparison of tuberculin skin testing and T-SPOT.TB for diagnosis of latent and active tuberculosis

Japanese Journal of Infectious Diseases

Volumn 63, Issue 2, 2010, Pages 99-102

  Simsek, Hulya ^a   Alpar, Sibel ^b   Uçar, Nazire ^b   Aksu, Funda ^b   Ceyhan, Ismail ^a   Gözalan, Aysegul ^a   Cesur, Salih ^c   Ertek, Mustafa ^a  

^a Refik Saydam National Public Health Agency   (Turkey)

^b Ataturk Chest Disease and Thoracic Surgery Education and Research Hospital Ankara   (Turkey)

^c Ankara Oncology Research and Training Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; FEMALE; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PREDICTION; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST;

ADOLESCENT; ADULT; AGED; CLINICAL LABORATORY TECHNIQUES; DIAGNOSTIC ERRORS; FEMALE; HUMANS; IMMUNOASSAY; INTERFERON-GAMMA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TUBERCULIN; TUBERCULOSIS; YOUNG ADULT;

EID: 77950645249     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. World Health Organization (2007): Global TB Control. p. 8-10. WHO Report.
2. Lagrange, P.H., Simonney, N. and Herrmann, J.L. (2007): New immunological tests in the diagnosis of tuberculosis. Rev. Mal. Respir., 24, 453-472.
3. Yaǧci, A. (2005): Malatya Sempozyum Kitabi{dotless}, p. 91-97. ESAT-6/CFP-10 Bazli{dotless} Elispot Tekniǧinin Tuberkuloz Tani{dotless}si{dotless}ndaki Yeri, IV. Tuberkuloz Sempozyumu (in Turkey).
4. Health Protection Agency. Tuberculosis. online at . Last updated December 2005. Accessed 24 February 2006.
5. Khan, A. (2008): Pulmonary and Critical Care Bulletin. vol. XIV, No. 1. p. 4-8. Interferon Gamma Release Assays for Diagnosis of Tuberculosis: Current Status.
6. Lalvani, A., Pathan, A.A., McShane, H., et al. (2001): Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigenspecific T cells. Am. J. Respir. Crit. Care Med., 163, 824-828.
7. Goletti, D., Vincenti, D., Carrara, S., et al. (2005): Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme- linked immunospot assay. Clin. Diagn. Lab. Immunol., 12, 1311-1316.
8. Hanif, S.N.M., El-Shammy, A.M., Al-Attiyah, R., et al. (2008): Whole blood assays to identify Th1 cell antigens and peptides encoded by Mycobacterium tuberculosis-specific RD1 genes. Med. Princ. Pract., 17, 244-249.
9. Mustafa, A.S. (2005): Recombinant and synthetic peptides to identify Mycobacterium tuberculosis antigens and epitopes of diagnostic and vaccine relevance. Tuberculosis, 85, 367-376.
10. Mori, T., Sakatani, M., Yamagishi, F., et al. (2004): Specific detection of tuberculosis infection: an interferon-γ-based assay using new antigens. Am. J. Respir. Crit. Care Med., 170, 59-64.
11. Comstock, G.W., Edwards, L.B., Philip, R.N., et al. (1964): A comparison in the United States of America of two tuberculins, TST-S and RT23. Bull. World Health Organ., 31, 161-170.
12. Geiter, L.J., Gordin, F.M., Hershfield, E., et al. (2000): Targeted tuberculin testing and treatment of latent tuberculosis infection. Am. J. Respir. Crit. Care Med., 161, S221-S247.
13. Elsie, L. and Holzman, R.S. (2002): Evolution and current use of the tuberculin test. Clin. Infect. Dis., 1, 34, 365-370.
14. Lalvani, A., Brookes, R., Hambleton, S., et al. (1997): Rapid effector functions in CD8+ memory T cells. J. Exp. Med., 186, 859-865.
15. Lalvani, A. (2003): Spotting latent infection: the path to better tuberculosis control. Thorax, 58, 916-918.
16. Gümüşlü, F., Özkara, Ş., Özkan, S., et al. (2007): The Report of Tuberculosis in Turkey in 2007. Department of Tuberculosis Control, Ankara.
17. Johnson, P.D., Stuart, R.L., Grayson, M.L., et al. (1999): Tuberculinpurified protein derivative, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and inpatients with tuberculosis. Clin. Diagn. Lab. Immunol., 6, 934-937.
18. Lalvani, A., Nagvenkar, P., Udwadia, Z., et al. (2001): Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J. Infect. Dis., 183, 469-477.
19. Kang, Y.A., Lee, H.W., Yoon, H.I., et al. (2005): Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA, 293, 2756-2761.
20. Lalvani, A., Pathan, A.A., Durkan, H., et al. (2001): Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet, 357, 2017-2021.
21. Meier, T., Eulenbruch, H.P., Wrighton-Smith, P., et al. (2005): Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur. J. Clin. Microbiol. Infect. Dis., 24, 529-536.
22. Kang, Y.A., Lee, H.W., Hwang, S.S., et al. (2007): Usefulness of whole- blood interferon-gamma assay and interferon gamma enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest, 132, 959-965.
23. Lee, J.Y., Choi, H.J., Park, I.N., et al. (2006): Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur. Respir. J., 28, 24-30.
24. Diel, R., Ernst, M., Döscher, G., et al. (2006): Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test. Eur. Respir. J., 28, 16-23.
25. Diel, R., Nienhaus, A., Lange, C., et al. (2006): Cost-optimization of screening for latent tuberculosis in close contacts. Eur. Respir. J., 28, 35-44.
26. Wrighton-Smith, P. and Zellweger, J.P. (2006): Direct costs of three models for the screening of latent tuberculosis infection. Eur. Respir. J., 28, 45-50.
27. National Collaborating Centre for Chronic Conditions (2006): Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. A clinical guideline for the NHS in England and Wales. Royal College of Physicians, London.
28. Ozekinci, T., Ozbek, E. and Celik, Y. (2007): Comparison of tuberculin skin test and a specific T-cell-based test, T-Spot.TB, for the diagnosis of latent tuberculosis infection. J. Int. Med. Res., 35, 696-703.